FDA Inspection 1266717 — Arif Dalvi, M.D., M.B.A.
The FDA completed an inspection of Arif Dalvi, M.D., M.B.A. on April 4, 2025 in Boynton Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Boynton Beach, FL (United States)
Additional Details
Clinical Investigator (CI)